Elon Musk’s brain-machine interface company Neuralink has a new job postingfor a clinical trial director, a position that could help the company move towards its stated goal of testing its brain implant in actual people.
Since launching publicly in 2017, Neuralink has demoed its brain implant in pigs and monkeys but has yet to announce a start to the long-promised trials in humans. The company’s implant is a coin-like device with electrodes studded on thin, flexible wires. The wires are its main innovation over older brain-machine interfaces, which use stiffer needles that can damage cells in the brain.
The company needs to do trials in humans before it can get Food and Drug Administration (FDA) approval for general medical use — key for Musk’s stated planto use the devices to solve a number of neurological problems, from memory loss to addiction.
The clinical trial director job posting, first reported by Bloomberg, says that the person in the role will be “working with Neuralink’s first Clinical Trial participants,” though it’s not clear if the company has started recruiting or working with participants at this point. Musk said in December that the company aims to have the device implanted in the first human subjects in 2022. That’s not the first prediction he’s made, though — Musk previously said he hoped to start trials in 2020.
See FULL STORY at The Verge.